Multiple intracardiac benign tumors treated with low-dose everolimus

Anatol J Cardiol. 2022 Feb;26(2):141-142. doi: 10.5152/AnatolJCardiol.2021.60.
No abstract available

MeSH terms

  • Antineoplastic Agents*
  • Everolimus / therapeutic use
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology

Substances

  • Antineoplastic Agents
  • Everolimus